X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 58 filers reported holding X4 PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 5.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $155,878 | -84.3% | 143,007 | -72.1% | 0.00% | – |
| Q2 2023 | $993,546 | +243.1% | 512,137 | +53.9% | 0.00% | – |
| Q1 2023 | $289,577 | +109.7% | 332,847 | +138.6% | 0.00% | – |
| Q4 2022 | $138,105 | -50.5% | 139,500 | -14.4% | 0.00% | – |
| Q3 2022 | $279,000 | +142.6% | 162,997 | +148.1% | 0.00% | – |
| Q1 2022 | $115,000 | -88.0% | 65,702 | -84.3% | 0.00% | – |
| Q4 2021 | $956,000 | -5.2% | 418,142 | +119.5% | 0.00% | – |
| Q3 2021 | $1,008,000 | +298.4% | 190,531 | +389.8% | 0.00% | – |
| Q2 2021 | $253,000 | -2.3% | 38,900 | +90.7% | 0.00% | – |
| Q3 2019 | $259,000 | -50.9% | 20,403 | -42.0% | 0.00% | – |
| Q2 2019 | $527,000 | – | 35,194 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,682,000 | 3.48% |
| Sio Capital Management, LLC | 804,597 | $6,928,000 | 1.41% |
| Bain Capital Life Sciences Investors, LLC | 2,119,540 | $18,249,000 | 1.03% |
| SV Health Investors, LLC | 311,490 | $2,682,000 | 1.00% |
| Monashee Investment Management LLC | 574,712 | $4,948,000 | 0.76% |
| Ikarian Capital, LLC | 2,614,988 | $22,515,000 | 0.76% |
| Abingworth LLP | 229,885 | $1,956,000 | 0.68% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,884,000 | 0.67% |
| BVF INC/IL | 1,091,579 | $9,398,000 | 0.35% |
| Endurant Capital Management LP | 151,996 | $1,309,000 | 0.34% |